Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Plos One|December 1, 2022
Risk factors for cerebral complications in patients with pulmonary arteriovenous malformations: A multicenter retrospective cohort studyYoung-Ok Na, Hwa Kyung Park, Jae-Kyeong Lee, et al.
Cells|May 13, 2023
Evaluation of Blood Tumor Mutation Burden for the Efficacy of Second-Line Atezolizumab Treatment in Non-Small Cell Lung Cancer: BUDDY TrialCheol-Kyu Park, Ha Ra Jun, Hyung-Joo Oh, et al.
Rheumatology International|October 23, 2009
Development of antisynthetase syndrome in a patient with rheumatoid arthritisCheol-Kyu Park, Tae-Jong Kim, Young-Nan Cho, et al.
Scientific Reports|October 23, 2023
Serum KL-6 levels predict the occurrence and severity of treatment-related interstitial lung disease in lung cancerHwa Kyung Park, Chang-Seok Yoon, Young-Ok Na, et al.
Journal for Immunotherapy of Cancer|February 26, 2025
Enhanced thrombopoiesis supplies PD-L1 to circulating immune cells via the generation of PD-L1-expressing platelets in patients with lung cancerSung-Woo Lee, Saei Jeong, Young Ju Kim, et al.
Anticancer Research|February 27, 2022
First-line Afatinib in Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in South KoreaMi-Hyun Kim, Chang Min Choi, Sung Yong Lee, et al.
Cancer Medicine|July 14, 2021
Sequential treatment of afatinib and osimertinib or other regimens in patients with advanced non-small-cell lung cancer harboring EGFR mutations: Results from a real-world study in South KoreaTaeyun Kim, Tae Won Jang, Chang Min Choi, et al.
Translational Lung Cancer Research|July 10, 2023
Real-world analysis of first-line afatinib in patients with EGFR-mutant non-small cell lung cancer and brain metastasis: survival and prognostic factorsJehun Kim, Tae Won Jang, Chang Min Choi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 21, 2023
Korean Real-World Data on Patients With Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy: PACIFIC-KRCheol-Kyu Park, Hyung-Joo Oh, Young-Chul Kim, et al.
Clinical Lung Cancer|February 11, 2017
Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non-Small-cell Lung Cancer: A TRAIL TrialCheol-Kyu Park, In-Jae Oh, Kyu-Sik Kim, et al.
Pageof 9